Is the societal approach wide enough to include relatives?: Incorporating relatives' costs and effects in a cost-effectiveness analysis

Applied Health Economics and Health Policy

Volumn 8, Issue 1, 2010, Pages 25-35

  Davidson, Thomas ^a   Levin, Lars Åke ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CAREGIVER; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; QUALITY OF LIFE; RELATIVE; REVIEW;

CAREGIVERS; COST OF ILLNESS; COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; QUALITY OF LIFE;

EID: 74249112704     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11313910-000000000-00000     Document Type: Review

References (49)

1. Donaldson C, Tarrier N, Burns A. Determinants of carer stress in Alzheimer's disease. Int J Geriatric Psychiatry 1998; 13: 248-256
2. Han B, Haley WE. Family caregiving for patients with stroke: review and analysis. Stroke 1999; 30: 1478-1485
3. Whitlatch CJ. Distress and burden for family caregivers. In: Wimo A, Jo?nsson B, Karlsson G, et al., editors. Health economics of dementia. Chichester: John Wiley & Sons, 1998: 123-138
4. Murphy N, Christian B, Caplin D, et al. The health of caregivers for children with disabilities: caregiver perspectives. Child Care Health Dev 2007; 33 (2): 180-187
5. Stolz P, Udé G,Willman A. Support for family carers who care for an elderly person at home: systematic review. Scand J Caring Sci 2004; 18: 111-119
6. Drummond MF, SculpherMJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press, 2005
7. Gold MR, Siegel JE, Russel LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
8. Brouwer WB, Van Exel NJA, Koopmanschap MA, et al. The valuation of informal care in economic appraisal: a consideration of individual choice and societal costs of time. Int J Technol Assess Health Care 1999; 15 (1): 147-160
9. Koopmanschap MA, Brouwer WB. Indirect costs and costing informal care. In:Wimo A, Jönsson B, Karlsson G, et al., editors. Health economics of dementia. Chichester: John Wiley & Sons, 1998: 245-256
10. Aneshensel CS, Pearlin LI, Schuler RH. Stress, role captivity, and the cessation of caregiving. J Health Soc Behav 1993; 34 (1): 54-70
11. Brouwer WB, Van Exel NJA, Van den Berg B, et al. Process utility from providing informal care: the benefit of caring. Health Pol 2005; 74: 85-99
12. Nolan MR, GrantG,Keady J.Understanding family care: a multidimensional model of caring and coping. Buckingham: Open University Press, 1996
13. White CL, Lauzon S, Yaffe MJ, et al. Toward a model of quality of life for family caregivers of stroke survivors. Qual Life Res 2004; 13: 625-638
14. Davidson T, Krevers B, Levin L-A? . In pursuit of QALY weights for relatives: empirical estimates in relatives caring for older people. Eur J Health Econ 2008; 9: 285-292
15. National Institute for Health and Clinical Excellence. Updated guide to the methods of technology appraisal. London: NICE, 2008 [online]. Available from URL: http:// www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdated June2008.pdf [Accessed 2009 Nov 30]
16. Läkemedelsförmånsnänden. General guidelines for economic evaluations from the Pharmaceutical Benefits Board. Stockholm: Pharmaceutical Benefits Board (Läemedelsförmånsnämnden), 2003 [online]. Available from URL: http://www.tlv.se/Upload/English/ENG-lfnar- 2003-2.pdf [Accessed 2009 Nov 30]
17. Basu A, Meltzer D. Implications of spillover effects within the family for medical cost-effectiveness analysis. J Health Econ 2005; 24: 751-773
18. Prosser L, Hammitt J, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics 2007; 25 (9): 713-726
19. National Institute for Health and Clinical Excellence. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (amended). London: NICE, 2007
20. Bolin K, Lindgren B, Lundborg P. Your next of kin or your own career? Caring and working among the 50+ of Europe. J Health Econ 2008; 27 (3): 718-738
21. Andrén S, Elmståhl S. Family caregivers' subjective experiences of satisfaction in dementia care: aspects of burden, subjective health and sense of coherence. Scand J Caring Sci 2005; 19: 157-168
22. Johannesson M. Theory and methods of economic evaluation of health care. Stockholm: Kluwer Academic Publishers, 1996
23. Culyer AJ. The normative economics of health care finance and provision. In:McGuire A, Fenn P, Mayhew K, editors. Providing health care: the economics of alternative systems of finance and provision. Oxford: Oxford University Press, 1991: 65-98
24. Williams A. Cost-benefit analysis: applied welfare economics or general decision aid. In: Williams A, Giardina E, editors. Efficiency in the public sector. London: Edward Elgar, 1993: 65-79
25. Birch S, Donaldson C. Valuing the benefits and costs of health care programmes: where's the 'extra' in extrawelfarism? Soc Sci Med 2003; 56: 1121-1133
26. Canadian agency for drugs and technologies in health. Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: CADTH, 2006 [online]. Available from URL: http://www.cadth.ca/media/pdf/186-Economic Guidelines-e.pdf [Accessed 2009 Nov 30]
27. Torrance GW, Feeny DH. Utilities and quality adjusted life years. Int J Technol Assess Health Care 1989; 5: 559-575
28. Van den Berg B, Brouwer WB, Koopmanschap MA. Economic valuation of informal care; an overview of methods and applications. Eur J Health Econ 2004; 5: 36-45
29. MulVaney-Day NE. Using willingness to pay to measure family members' preferences in mental health. J Ment Health Pol Econ 2005; 8: 71-81
30. Van den Berg B, Bleichrodt H, Eeckhoudt L. The economic value of informal care: a study of informal caregivers' and patients' willingness to pay and willingness to accept for informal care. Health Econ 2005; 14: 363-376
31. Van den Berg B, Brouwer WB, Van Exel NJA, et al. Economic valuation of informal care: the contingent valuation method applied to informal caregiving. Health Econ 2005; 14 (2): 169-183
32. Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med 1999; 48: 535-546
33. Ryan M, Hughes J. Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ 1997; 6: 261-273
34. Van den Berg B, Al M, Van Exel NJA, et al. Economic valuation of informal care: conjoint analysis applied in a heterogeneous population of informal caregivers. Value Health 2008; 11 (7): 1041-1050
35. Van den Berg B, Maiwenn A, Brouwer W, et al. Economic valuation of informal care: the conjoint measurement method applied to informal caregiving. Soc Sci Med 2005; 61: 1342-1355 (Pubitemid 40828577)
36. Ferrer-i-Carbonell A, Van Praag BMS. The subjective costs of health losses due to chronic diseases: an alternative model for monetary appraisal. Health Econ 2002; 11: 709-722
37. Van den Berg B, Ferrer-i-Carbonell A. Monetary valuation of informal care: the well-being valuation method. Health Econ 2007; 16 (11): 1227-1244
38. Busschbach JJV, Brouwer WB, Van der Donk A, et al. An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease. Pharmacoeconomics 1998; 13 (1): 21-34
39. Mohide EA, Torrance GW, Streiner DL, et al. Measuring the wellbeing of family caregivers using the time trade-off technique. J Clin Epidemiol 1988; 41 (5): 475-482
40. Prosser LA, Bridges CB, Uyeki TM, et al. Values for preventing influenza-related morbidity and vaccine adverse events in children. Health Qual Life Outcomes 2005; 3: 18
41. McMillan SC, Mahon MM. The impact of hospice services on the quality of life of primary caregivers. Oncol Nurs Forum 1994 Aug; 21 (7): 1189-1195
42. Brouwer W, Van Exel N, Van Gorp B, et al. The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations. Qual Life Res 2006; 15: 1005-1021
43. Johannesson M, Liljas B, O'Connor RM. Hypothetical versus real willingness to pay: some experimental results. Appl Econ Lett 1997; 4: 149-151 (Pubitemid 127621284)
44. Karlsson G, Jönsson B, Wimo A, et al. Methodological issues in health economic studies of dementia. In: Wimo A, Jönsson B, Karlsson G, et al., editors. Health economics of dementia. Chichester: John Wiley & Sons, 1998: 161-170
45. Arrow K. A difficulty in the concept of social welfare. J Pol Econ 1950; 58 (4): 328-346
46. Koopmanschap MA, Van Exel NJA, Van den Berg B, et al. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics 2008; 26 (4): 269-280
47. Brouwer WB. Too important to ignore: informal caregivers and other significant others. Pharmacoeconomics 2006; 24 (1): 39-41
48. Brouwer WB, Van Exel NJA, Van den Berg B, et al. Burden of caregiving: evidence of objective burden, subjective burden, and quality of life impacts on informal caregivers of patients with rheumatoid arthritis. Arthritis Rheum 2004; 51 (4): 570-577
49. Dixon S, Walker M, Salek S. Incorporating carer effects into economic evaluation. Pharmacoeconomics 2006; 24 (1): 43-53